As of mid-2024, a full 6% of US adults are actively taking GLP-1 agonists , but the huge potential addressable market for these drugs, combined with an ongoing shortage, means that these medications have plenty of additional potential running room
2023 (Int J Food Sci Nutr) Meta-analysis of systematic reviews on ginger for nausea and vomiting
In the REDEFINE 1 trial, CagriSema produced 20.4% body weight loss over 68 weeks
Clinical data support the use of Ipamorelin as a safe long-term treatment
Treatment Products: If you have specific skin concerns like acne or aging, apply any treatment products, such as retinol or acne treatments, after cleansing
Amylin, GIP, glucagon, and combination protocols are changing what serious tracking should include